REVIEW: γ‐Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State

Aims: Drugs currently used for the treatment of Alzheimer's disease (AD) partially stabilize patients’ symptoms without modifying disease progression. Brain accumulation of oligomeric species of β‐amyloid (Aβ) peptides, the principal components of senile plaques, is believed to play a crucial r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:CNS Neurosci Ther
Main Authors: Panza, Francesco, Frisardi, Vincenza, Imbimbo, Bruno P., Capurso, Cristiano, Logroscino, Giancarlo, Sancarlo, Daniele, Seripa, Davide, Vendemiale, Gianluigi, Pilotto, Alberto, Solfrizzi, Vincenzo
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2010
Assuntos:
Alzheimer's Disease
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493789/
https://ncbi.nlm.nih.gov/pubmed/20560993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2010.00164.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares